iShares Edge MSCI Europe Momentum Factor UCITS ETF (ETR:CEMR)
Germany · Delayed Price · Currency is EUR | Assets | 789.95M |
| Expense Ratio | 0.25% |
| PE Ratio | 17.07 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +17.72% |
| Volume | 105,792 |
| Open | 15.66 |
| Previous Close | 15.72 |
| Day's Range | 15.54 - 15.67 |
| 52-Week Low | 12.90 |
| 52-Week High | 15.98 |
| Beta | 1.05 |
| Holdings | 145 |
| Inception Date | Jan 16, 2015 |
About CEMR
iShares Edge MSCI Europe Momentum Factor UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of developed markets in Europe. It seeks to invest in the stocks companies operating across diversified sectors. The fund invests in the momentum stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Europe Momentum Index, by employing representative sampling methodology. The fund was formerly known as iShares IV Public Limited Company - iShares MSCI Europe Momentum Factor UCITS ETF. iShares Edge MSCI Europe Momentum Factor UCITS ETF was formed on October 28, 2014 and is domiciled in Ireland.
Performance
CEMR had a total return of 17.72% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.02%.
Top 10 Holdings
38.22% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.99% |
| HSBC Holdings plc | HSBA | 4.92% |
| Novartis AG | NOVN | 4.22% |
| Roche Holding AG | ROP | 4.13% |
| Iberdrola, S.A. | IBE | 3.83% |
| Banco Santander, S.A. | SAN | 3.77% |
| Siemens Energy AG | ENR | 3.58% |
| TotalEnergies SE | TTE | 3.13% |
| Shell plc | SHEL | 2.94% |
| AstraZeneca PLC | AZN | 2.72% |